June 19, 2019
GenSight Biologics expands its Board of Directors with the appointments of Maritza McIntyre and Sofinnova Partners
Media
June 16, 2019
New Data Presented from Oncopeptides’ Pivotal Phase 2 HORIZON Trial Evaluating Melflufen in Relapsed/Refractory Multiple Myeloma at 24th EHA Congress
June 14, 2019
New Data Presented at 24th EHA Congress from Oncopeptides’ Phase 1/2 ANCHOR Trial Evaluating Melflufen in Relapsed/Refractory Multiple Myeloma (RRMM)
June 13, 2019
Oncopeptides will host a Webcast on Monday, 17 June at 09:00 (CET) to review and update presentations from European Hematology (EHA) meeting
June 12, 2019
Strongbridge Biopharma plc to Present at the 2019 JMP Securities Life Sciences Conference
June 12, 2019
Altimmune Appoints Will Brown as Chief Financial Officer
June 10, 2019
Altimmune Announces Successful Pre-IND Meeting with FDA
June 05, 2019
Altimmune Announces Important Additions to its Patent Portfolio for HepTcell and ALT-702 Programs
June 04, 2019
Strongbridge Biopharma plc Strengthens Senior Leadership Team with Key Promotion and Appointment
June 03, 2019
New Data from Oncopeptides Phase 1/2 O-12-M1 Trial Evaluating Melflufen in RRMM Presented at 2019 ASCO Annual Meeting
